NCT01240096View on ClinicalTrials.gov

Mirtazapine Versus Placebo in Functional Dyspepsia

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 1, 2006

Primary Completion Date

August 1, 2011

Study Completion Date

September 11, 2012

Conditions
Functional Dyspepsia
Interventions
DRUG

Mirtazapine

Mirtazapine 15 mg daily

Trial Locations (1)

3000

University Hospitals, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01240096 - Mirtazapine Versus Placebo in Functional Dyspepsia | Biotech Hunter | Biotech Hunter